Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139


A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma.

Loyo M, Brait M, Kim MS, Ostrow KL, Jie CC, Chuang AY, Califano JA, Li├ęgeois NJ, Begum S, Westra WH, Hoque MO, Tao Q, Sidransky D.

Int J Cancer. 2011 Mar 15;128(6):1393-403. doi: 10.1002/ijc.25443.


The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.

Seng TJ, Low JS, Li H, Cui Y, Goh HK, Wong ML, Srivastava G, Sidransky D, Califano J, Steenbergen RD, Rha SY, Tan J, Hsieh WS, Ambinder RF, Lin X, Chan AT, Tao Q.

Oncogene. 2007 Feb 8;26(6):934-44. Epub 2006 Jul 24.


Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.

Zhang Z, Sun D, Van do N, Tang A, Hu L, Huang G.

Int J Cancer. 2007 Jan 1;120(1):32-8.


Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma.

Tian F, Yip SP, Kwong DL, Lin Z, Yang Z, Wu VW.

Cancer Epidemiol. 2013 Oct;37(5):708-13. doi: 10.1016/j.canep.2013.05.012. Epub 2013 Jun 20.


Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.

Tong JH, Ng DC, Chau SL, So KK, Leung PP, Lee TL, Lung RW, Chan MW, Chan AW, Lo KW, To KF.

BMC Cancer. 2010 Jun 3;10:253. doi: 10.1186/1471-2407-10-253.


Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.

Yang X, Dai W, Kwong DL, Szeto CY, Wong EH, Ng WT, Lee AW, Ngan RK, Yau CC, Tung SY, Lung ML.

Int J Cancer. 2015 Feb 15;136(4):E127-35. doi: 10.1002/ijc.29192. Epub 2014 Sep 19.


Integrin ╬▒9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma.

Nawaz I, Hu LF, Du ZM, Moumad K, Ignatyev I, Pavlova TV, Kashuba V, Almgren M, Zabarovsky ER, Ernberg I.

Oncotarget. 2015 Oct 13;6(31):31493-507. doi: 10.18632/oncotarget.5154.


Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.

Kwong J, Lo KW, Chow LS, Chan FL, To KF, Huang DP.

Int J Cancer. 2005 Jan 20;113(3):386-92.


Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.

Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP.

Mol Carcinog. 2003 Dec;38(4):170-8.


TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.

Wang S, Xiao X, Zhou X, Huang T, Du C, Yu N, Mo Y, Lin L, Zhang J, Ma N, Murata M, Huang G, Zhang Z.

BMC Cancer. 2010 Nov 9;10:617. doi: 10.1186/1471-2407-10-617.


Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma.

Wang T, Liu H, Chen Y, Liu W, Yu J, Wu G.

J Exp Clin Cancer Res. 2009 Dec 30;28:160. doi: 10.1186/1756-9966-28-160.


The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.

Chan SL, Cui Y, van Hasselt A, Li H, Srivastava G, Jin H, Ng KM, Wang Y, Lee KY, Tsao GS, Zhong S, Robertson KD, Rha SY, Chan AT, Tao Q.

Lab Invest. 2007 Jul;87(7):644-50. Epub 2007 Mar 26.


CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma.

Du C, Huang T, Sun D, Mo Y, Feng H, Zhou X, Xiao X, Yu N, Hou B, Huang G, Ernberg I, Zhang Z.

Cancer Lett. 2011 Oct 1;309(1):54-61. doi: 10.1016/j.canlet.2011.05.016. Epub 2011 Jun 12.


Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.

Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW, Putti T, Murray P, Chan AT, Tao Q.

Oncogene. 2006 Feb 16;25(7):1070-80.


Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient.

Chang HW, Chan A, Kwong DL, Wei WI, Sham JS, Yuen AP.

Int J Cancer. 2003 Jul 20;105(6):851-5. Erratum in: Int J Cancer. 2003 Oct 10;106(6):984.


RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.

Chow LS, Lo KW, Kwong J, To KF, Tsang KS, Lam CW, Dammann R, Huang DP.

Int J Cancer. 2004 May 10;109(6):839-47.


FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma.

Shu XS, Li L, Ji M, Cheng Y, Ying J, Fan Y, Zhong L, Liu X, Tsao SW, Chan AT, Tao Q.

Carcinogenesis. 2013 Sep;34(9):1984-93. doi: 10.1093/carcin/bgt165. Epub 2013 May 14.


Supplemental Content

Support Center